Nimblify’s Participant Payment System Makes Its Debut
Participant Payments provides clinical research sites the choice to pay participants via reloadable debit card, direct deposit or check.
Nimblify, Inc., a clinical trials technology company and wholly owned subsidiary of Forte Research Systems, has launched its first offering, a participant-centered payment system. Participant Payments provides clinical research sites the choice to pay participants via reloadable debit card, direct deposit or check, without additional work for the site. In addition to an improved patient experience, Participant Payments provides coordinators the ability to set clear expectations with participants with the help of protocol-specific guidelines, including pre-approved stipend amounts and maximums for hotel and parking reimbursements.
Read the full
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025